We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+16.68%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$88.8B
AUM Growth
+$10B
(+13%)
Cap. Flow
+$220M
Cap. Flow
% of AUM
0.25%
Top 10 Holdings %
Top 10 Hldgs %
31.47%
Holding
3,325
New
753
Increased
947
Reduced
893
Closed
691
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRCL
Circle Internet Group
CRCL
|
+$1.39B |
| 2 |
NVIDIA
NVDA
|
+$910M |
| 3 |
Amazon
AMZN
|
+$440M |
| 4 |
T-Mobile US
TMUS
|
+$432M |
| 5 |
Eli Lilly
LLY
|
+$398M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.3B |
| 2 |
Tesla
TSLA
|
+$880M |
| 3 |
Danaher
DHR
|
+$535M |
| 4 |
Intuit
INTU
|
+$467M |
| 5 |
Visa
V
|
+$437M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.88% |
| 2 | Consumer Discretionary | 13.54% |
| 3 | Healthcare | 10.42% |
| 4 | Financials | 8.78% |
| 5 | Communication Services | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
FibroBiologics
FBLG
$6.53M
| $48.7K | ﹤0.01% |
+3,931
| New | +$70.9K |
|
2577
Wrap Technologies
WRAP
$102M
| $46.4K | ﹤0.01% |
29,735
-134,888
| -82% | -$203K |
|
|
CLYM
2578
Climb Bio
CLYM
$778M
| $45.6K | ﹤0.01% |
+36,738
| New | +$45.7K |
|
2579
ALX Oncology
ALXO
$285M
| $44.6K | ﹤0.01% |
106,280
-164,917
| -61% | -$83.2K |
|
2580
PepGen
PEPG
$207M
| $43.5K | ﹤0.01% |
+39,209
| New | +$55.4K |
|
|
BORR
2581
Borr Drilling
BORR
$1.28B
| $43.3K | ﹤0.01% |
23,651
-1,523,564
| -98% | -$2.88M |
|
|
HLVX
2582
DELISTED
HilleVax
HLVX
| $42.6K | ﹤0.01% |
+21,400
| New | +$39.1K |
|
|
TEAD
2583
Teads Holding Co
TEAD
$64.5M
| $42.2K | ﹤0.01% |
17,021
-345,059
| -95% | -$1.04M |
|
2584
Outlook Therapeutics
OTLK
$215M
| $40.9K | ﹤0.01% |
+25,564
| New | +$40.8K |
|
2585
Kosmos Energy
KOS
$1.49B
| $40.5K | ﹤0.01% |
23,535
| – | – |
|
|
NXDR
2586
Nextdoor Holdings
NXDR
$1.04B
| $40K | ﹤0.01% |
24,100
-59,176
| -71% | -$89.3K |
|
2587
Anixa Biosciences
ANIX
$111M
| $38.7K | ﹤0.01% |
+11,722
| New | +$33.5K |
|
2588
Tiziana Life Sciences
TLSA
$129M
| $38.5K | ﹤0.01% |
+24,369
| New | +$32.6K |
|
2589
New Horizon Aircraft
HOVR
$136M
| $38.5K | ﹤0.01% |
+22,514
| New | +$19.8K |
|
|
KLRS
2590
Kalaris Therapeutics
KLRS
$93.7M
| $37.7K | ﹤0.01% |
14,115
| – | – |
|
|
GBIO
2591
DELISTED
Generation Bio
GBIO
| $37.2K | ﹤0.01% |
+11,620
| New | +$44.8K |
|
2592
Designer Brands
DBI
$334M
| $37.1K | ﹤0.01% |
15,600
-314,508
| -95% | -$950K |
|
2593
Immunic
IMUX
$192M
| $35K | ﹤0.01% |
4,999
-51,355
| -91% | -$471K |
|
2594
Prelude Therapeutics
PRLD
$385M
| $33.8K | ﹤0.01% |
+41,747
| New | +$36.1K |
|
2595
State Street SPDR S&P 500 ETF Trust
SPY
$810B
| $32.7K | ﹤0.01% |
53
-7,403
| -99% | -$4.23M |
|
2596
BioAtla
BCAB
$5.76M
| $32.3K | ﹤0.01% |
1,617
-110
| -6% | -$2.23K |
|
|
THM
2597
International Tower Hill Mines
THM
$699M
| $32.3K | ﹤0.01% |
+37,551
| New | +$28.5K |
|
2598
CALL
Qualcomm
QCOM
$170B
| $31.9K | ﹤0.01% |
200
| – | – |
|
2599
Douglas Elliman
DOUG
$166M
| $30.7K | ﹤0.01% |
13,242
-111,371
| -89% | -$238K |
|
2600
MAIA Biotechnology
MAIA
$85.7M
| $29.1K | ﹤0.01% |
+16,165
| New | +$28.9K |
|
Similar funds
Marshall Wace's Q2 2025 Portfolio in Review
As of Q2 2025, Marshall Wace held 3,325 positions worth $88.8B, up 13% from $78.8B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Marshall Wace's Q2 2025 filing shows 753 new, 947 increased, 893 reduced and 691 closed positions. Its largest new stake was Circle Internet Group: 8,534,470 shares worth $1.55B. The largest sale was iShares Core S&P 500 ETF, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Marshall Wace's largest Q2 2025 buy was Circle Internet Group: 8,534,470 shares worth $1.55B.
- Marshall Wace added most to NVIDIA in Q2 2025, an estimated $910M increase.
- Marshall Wace's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.3B.
- Marshall Wace fully exited Cboe Global Markets in Q2 2025, selling an estimated $191M.
- Marshall Wace's ten largest holdings make up 31% of its $88.8B portfolio in Q2 2025.
- Marshall Wace opened 753 new positions and closed 691 in Q2 2025.
- Marshall Wace's portfolio value rose 13% quarter-over-quarter to $88.8B.
Based on Marshall Wace's 13F filing for Q2 2025, filed 13 Aug 2025.